[ Price : $8.95]
FDA accepts for review an NPS Pharmaceuticals supplemental NDA for Gattex (teduglutide [rDNA origin]) for injection, which is curr...[ Price : $8.95]
FDA asks manufacturers of certain OTC topical antiseptics to revise the products labels and packaging to help prevent infections i...[ Price : $8.95]
FDA grants Mast Therapeutics an orphan drug designation for MST-188 for treating acute limb ischemia.[ Price : $8.95]
FDA tells Sarepta Therapeutics that its planned NDA filing is premature for eteplirsen and its use in treating Duchenne muscular d...[ Price : $8.95]
CDER medical reviewers tell the Peripheral and Central Nervous System Advisory Committee that they recommend approval of Vanda Pha...[ Price : $8.95]
GlaxoSmithKline says its darapladib failed to meet the primary endpoint in a Phase 3 trial of its use in adults with chronic coron...[ Price : $8.95]
Nautilus asks FDA to reconsider its request for a deferral of pediatric studies of its migraine analgesic Cambia.[ Price : $8.95]
FDA clears an IntelligentMDx 510(k) for its IMDx C. difficile for use with Abbotts m2000 assay.